<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="./PMC7073423/results/search/disease/results.xml">
  <result pre="Reviews: 4 Protection of healthcare workers against transmission of Mycobacterium" exact="tuberculosis" post="in hospitals: a review of the evidence Protection of"/>
  <result pre="review of the evidence Protection of healthcare workers against M." exact="tuberculosis" post="Diel Roland 1 2 3 4 Nienhaus Albert 3"/>
  <result pre="Non-Commercial Licence 4.0. Abstract Background Employees in contact with infectious" exact="tuberculosis" post="(TB) patients in healthcare facilities of low-incidence countries are"/>
  <result pre="ward and during aerosol-generating procedures is key to reducing Mycobacterium" exact="tuberculosis" post="exposure. However, there is no consensus on the types"/>
  <result pre="differ, too, as to whether long-term control measures for M." exact="tuberculosis" post="infections in healthcare workers by serial testing for latent"/>
  <result pre="German recommendations on protecting employees in healthcare facilities against M." exact="tuberculosis" post="transmission show considerable practical discrepancies. Harmonisation and practical amendments"/>
  <result pre="As there were an estimated 1.2 million (range, 1.1–1.3 million)" exact="tuberculosis" post="(TB) deaths among HIV-negative people in 2018 [ 1]"/>
  <result pre="patients in healthcare facilities are at considerable risk of Mycobacterium" exact="tuberculosis" post="transmission [ 2]. Current guidelines suggest a bundle of"/>
  <result pre="drug-resistant TB should wear FFP2 masks. Given that drug-resistant M." exact="tuberculosis" post="strains are not any more contagious than susceptible strains,"/>
  <result pre="registered by the US Environmental Protection Agency for use against" exact="hepatitis" post="B virus, HIV or M. tuberculosis specify a contact"/>
  <result pre="Agency for use against hepatitis B virus, HIV or M." exact="tuberculosis" post="specify a contact time of 10 min, but that significant"/>
  <result pre="is achieved by the dilution or elimination of infectious M." exact="tuberculosis" post="droplets, by means of sufficient ventilation, from the contaminated"/>
  <result pre="Air changes per hour (ACH) and removal efficiencies of Mycobacterium" exact="tuberculosis" post="droplets ACH Time required for removal efficiency min 99%"/>
  <result pre="short-wavelength ultraviolet (UV-C) light to kill or inactivate airborne M." exact="tuberculosis" post="by destroying its DNA. Wavelengths of between about 200 nm"/>
  <result pre="for that impressive success. Isolation and removal of isolation M." exact="tuberculosis" post="is carried in airborne particles, called droplet nuclei, of"/>
  <result pre="theoretically one single droplet is sufficient to produce an M." exact="tuberculosis" post="infection, in praxi several thousands of mycobacteria, inhaled simultaneously"/>
  <result pre="of guidelines on selected preventive measures for protection against Mycobacterium" exact="tuberculosis" post="in hospitals separated by topics Guidelines/recommendations WHO [ 6,"/>
  <result pre="but no recommendation provided Minimum 2-week treatment, progressively decreasing M." exact="tuberculosis" post="load, then 3 microscopy-negative sputum smear-results Only after at"/>
  <result pre="be established in official country guidelines. MDR-TB MDR-TB, defined as" exact="tuberculosis" post="disease caused by a M. tuberculosis strain that is"/>
  <result pre="MDR-TB MDR-TB, defined as tuberculosis disease caused by a M." exact="tuberculosis" post="strain that is resistant at least to the two"/>
  <result pre="a positive IGRA result also represents an infection with M." exact="tuberculosis" post="depends on its positive predictive value (PPV), an a"/>
  <result pre="importantly, on the proportion (prevalence, pre-test probability) of latent M." exact="tuberculosis" post="infection in the investigated collective. PPV is calculated as"/>
  <result pre="is rare, there is not a high risk of M." exact="tuberculosis" post="infection in general for all healthcare activities. It is"/>
  <result pre="that approximately 3% of US HCWs scored positive for M." exact="tuberculosis" post="at baseline when tested with TST and 5% scored"/>
  <result pre="WHO, USA, UK and Germany on protecting HCWs from M." exact="tuberculosis" post="transmission in healthcare facilities show considerable practical discrepancies (see"/>
  <result pre="Diel R , Niemann S , Nienhaus A Risk of" exact="tuberculosis" post="transmission among healthcare workers. ERJ Open Res 2018; 4:"/>
  <result pre=", et al. Guidelines for preventing the transmission of Mycobacterium" exact="tuberculosis" post="in health-care settings, 2005 . MMWR Recomm Rep 2005;"/>
  <result pre="WHO, 2009. 7 collab: World Health Organization. WHO guidelines on" exact="tuberculosis" post="infection prevention and control, 2019 update. Geneva, WHO, 2019."/>
  <result pre="the control of tuberculosis. Recommendations for personal respiratory protection in" exact="tuberculosis" post=". Pneumologie 2004; 58: 92– 102. doi: 10.1055/s-2003-812527 14961438"/>
  <result pre="K , Uthaivoravit W , et al. Risk of Mycobacterium" exact="tuberculosis" post="infection and disease among health care workers, Chiang Rai,"/>
  <result pre="al. The early bactericidal activity of drugs in patients with" exact="pulmonary tuberculosis." post="Am Rev Respir Dis 1980; 121: 939– 949. 6774638"/>
  <result pre="value of contact investigation for identifying recent transmission of Mycobacterium" exact="tuberculosis" post=". Am J Respir Crit Care Med 1998; 158:"/>
  <result pre="last accessed: August 25, 2019. 25 Control and prevention of" exact="tuberculosis" post="in the United Kingdom: code of practice 2000. Joint"/>
  <result pre="Performance of the Xpert MTB/RIF assay for the diagnosis of" exact="pulmonary tuberculosis" post="and rifampin resistance in a low-incidence, high resource setting"/>
  <result pre="of the Xpert MTB/RIF assay for the diagnosis of pulmonary" exact="tuberculosis" post="and rifampin resistance in a low-incidence, high resource setting"/>
  <result pre="Martin L , et al. Transmission of multidrug-resistant and drug-susceptible" exact="tuberculosis" post="within households: a prospective cohort study . PLoS Med"/>
  <result pre="L , Gilman RH , et al. Prolonged infectiousness of" exact="tuberculosis" post="patients in a directly observed therapy short-course program with"/>
  <result pre="R Review of epidemiological studies on the occupational risk of" exact="tuberculosis" post="in low-incidence areas . Respiration 2005; 72: 431– 446."/>
  <result pre="In Tube assay, and T-Spot.TB test in contact investigations for" exact="tuberculosis" post=". Chest 2009; 135: 1010– 1018. doi: 10.1378/chest.08-2048 19017873"/>
  <result pre="the healthcare sector in a country with low incidence for" exact="tuberculosis" post="- a prospective cohort study . GMS Hyg Infect"/>
  <result pre="2013; 8: Doc17. 24327943 37 collab: World Health Organisation. Latent" exact="tuberculosis" post="infection: updated and consolidated guidelines for programmatic management ."/>
 </snippets>
</snippetsTree>
